Technology ID
TAB-4877

High-Frequency Cell Mechanics for Health and Viability Assessment

E-Numbers
E-056-2014-0
Lead Inventor
Desai, Sanjay
Lead IC
NIAID
Co-Inventors
Sawetzki, Tobias
Marr, David
Eggleton, Charles
ICs
NIAID
Applications
Research Materials
Medical Devices
Diagnostics
Therapeutic Areas
Oncology
Immunology
Cardiology
Development Stages
Prototype
Research Products
Research Equipment
Computational models/software

The groundbreaking technology of high-frequency cell mechanics assessment represents a paradigm shift in the field of cell analysis. This innovation enables rapid and non-invasive evaluation of cell health and viability, eliminating the need for cell labeling or modification. By measuring cell viscoelastic properties at high frequencies, it offers real-time insights into the mechanical characteristics of individual cells and entire populations. With versatile applications across biomedical research, drug discovery, disease diagnosis, and bioprocessing quality control, this technology has the potential to revolutionize cell analysis, accelerate drug development, improve disease diagnosis, and deepen our understanding of cellular biomechanics, all while offering a non-destructive and high-throughput approach to assessing cell populations.

 

Commercial Applications
This technology finds applications in various domains. It enhances biomedical research by studying cell behavior and biomechanics. In drug discovery, it streamlines candidate screening. Disease diagnosis benefits from its ability to detect abnormalities early. It ensures quality in bioprocessing and offers versatile tools for research, pharmaceuticals, diagnostics, and biotechnology.

Competitive Advantages
This high-frequency cell mechanics assessment technology excels with its non-invasive approach, eliminating cell labeling, preserving natural states, and enabling high-throughput, real-time analysis. Its versatility spans biomedicine, pharmaceuticals, diagnostics, and biotechnology, making it a disruptive force in cell analysis, accelerating research, drug development, and disease diagnosis while maintaining cell integrity and efficiency.
Licensing Contact: